PTGX EBITDA Margin

Protagonist Therapeutics Inc · EBITDA Margin

PTGX logo

PTGX EBITDA Margin

Latest reported30.45%
PTGX EBITDA Margin (0.00% → 30.45%)
High-resolution chart · PNG

PTGX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Protagonist Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-278.2315%
64.9976%
-126.0717%
-466.5889%
-448.7919%
-215.8481%
-32,547.619%
-126.7454%
-182.1811%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.